New weapon for primary biliary cirrhosis from Japan.
Zeniya
Mikio
M
D001629:Bezafibrate / Q000627:therapeutic use*; D001647:Bile Acids and Salts / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy*; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D001647:Bile Acids and Salts; D000960:Hypolipidemic Agents; D014580:Ursodeoxycholic Acid; D001629:Bezafibrate